ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976

Prevention Trial Could Stand On Its Own

October 28, 1994

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Cornel Student Withdraws In Wake Of Discrepancies Found In Study

September 18, 1981

IOM Report: Nationwide Crisis Facing Cancer Care

September 13, 2013

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979